Literature DB >> 7636967

Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.

M Pope1, O Rotstein, E Cole, S Sinclair, R Parr, B Cruz, R Fingerote, S Chung, R Gorczynski, L Fung.   

Abstract

Murine hepatitis virus strain (MHV-3) produces a strain-dependent pattern of disease which has been used as a model for fulminant viral hepatitis. This study was undertaken to examine whether there was a correlation between macrophage activation and susceptibility or resistance to MHV-3 infection. Peritoneal macrophages were isolated from resistant A/J and susceptible BALB/cJ mice and, following stimulation with MHV-3 or lipopolysaccharide (LPS), analyzed for transcription of mRNA and production of interleukin-1 (IL-1), tumor necrosis factor alpha (TNF-alpha), transforming growth factor beta (TGF-beta), mouse fibrinogen-like protein (musfiblp), tissue factor (TF), leukotriene B4, and prostaglandin E2 (PGE2). Macrophages from BALB/cJ mice produced greater amounts of IL-1, TNF-alpha, TGF-beta, leukotriene B4, and musfiblp following MHV-3 infection than macrophages from resistant A/J mice, whereas in response to LPS, equivalent amounts of IL-1, TNF-alpha, TGF-beta, and TF were produced by macrophages from both strains of mice. Levels of mRNA of IL-1, TNF-alpha, and musfiblp were greater and more persistent in BALB/cJ than in A/J macrophages, whereas the levels and kinetics of IL-1, TNF-alpha, and TF mRNA following LPS stimulation were identical in macrophages from both strains of mice. Levels of production of PGE2 by MHV-3-stimulated macrophages from resistant and susceptible mice were equivalent; however, the time course for induction of PGE2, differed, but the total quantity of PGE2 produced was insufficient to inhibit induction of musfiblp, a procoagulant known to correlate with development of fulminant hepatic necrosis in susceptible mice. These results demonstrate marked differences in production of inflammatory mediators to MHV-3 infection in macrophages from resistant A/J and susceptible BALB/cJ mice, which may explain the marked hepatic necrosis and fibrin deposition and account for the lethality of MHV-3 in susceptible mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636967      PMCID: PMC189358     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Leukotrienes as mediators in frog virus 3-induced hepatitis in rats.

Authors:  W Hagmann; A M Steffan; A Kirn; D Keppler
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

Review 3.  Difficult management problems in fulminant hepatic failure.

Authors:  S J Muñoz
Journal:  Semin Liver Dis       Date:  1993-11       Impact factor: 6.115

4.  Infection of BALB/cByJ mice with the JHM strain of mouse hepatitis virus alters in vitro splenic T cell proliferation and cytokine production.

Authors:  M S de Souza; A L Smith; K Bottomly
Journal:  Lab Anim Sci       Date:  1991-04

5.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

Authors:  S L Kunkel; R C Wiggins; S W Chensue; J Larrick
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

6.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

7.  A radioimmunoassay for 6-keto-prostaglandin F1 alpha.

Authors:  L M Demers; D D Derck
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

8.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; R S Cotran; M A Gimbrone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

9.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

10.  Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3.

Authors:  P J MacPhee; V J Dindzans; L S Fung; G A Levy
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

View more
  17 in total

Review 1.  The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Authors:  Jiemiao Hu; Jun Yan; Ganesh Rao; Khatri Latha; Willem W Overwijk; Amy B Heimberger; Shulin Li
Journal:  Int Rev Immunol       Date:  2014-09-26       Impact factor: 5.311

2.  Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.

Authors:  J S Orange; T P Salazar-Mather; S M Opal; C A Biron
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase.

Authors:  J W Ding; Q Ning; M F Liu; A Lai; J Leibowitz; K M Peltekian; E H Cole; L S Fung; C Holloway; P A Marsden; H Yeger; M J Phillips; G A Levy
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Physiological functions and clinical implications of fibrinogen-like 2: A review.

Authors:  Genyan Yang; W Craig Hooper
Journal:  World J Clin Infect Dis       Date:  2013-08-25

5.  Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide.

Authors:  M Pope; P A Marsden; E Cole; S Sloan; L S Fung; Q Ning; J W Ding; J L Leibowitz; M J Phillips; G A Levy
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis.

Authors:  Xue-Zhong Ma; Agata Bartczak; Jianhua Zhang; Wei He; Itay Shalev; David Smil; Limin Chen; Jim Phillips; Jordan J Feld; Nazia Selzner; Gary Levy; Ian McGilvray
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

7.  Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection.

Authors:  Yongwen Chen; Shengxi Wu; Guoning Guo; Lei Fei; Sheng Guo; Chengying Yang; Xiaolan Fu; Yuzhang Wu
Journal:  PLoS Pathog       Date:  2011-07-07       Impact factor: 6.823

8.  Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis.

Authors:  G A Levy; M Liu; J Ding; S Yuwaraj; J Leibowitz; P A Marsden; Q Ning; A Kovalinka; M J Phillips
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

9.  The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection.

Authors:  Itay Shalev; Nazia Selzner; Ahmed Helmy; Katharina Foerster; Oyedele A Adeyi; David R Grant; Gary Levy
Journal:  Rambam Maimonides Med J       Date:  2010-07-02

10.  Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection.

Authors:  Matthijs Raaben; Alexandra W C Einerhand; Lucas J A Taminiau; Michel van Houdt; Janneke Bouma; Rolien H Raatgeep; Hans A Büller; Cornelis A M de Haan; John W A Rossen
Journal:  Virol J       Date:  2007-06-07       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.